Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 9, 2021Journal of Clinical OncologyOpen Access

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

RNRyotaro NakamuraWSWael SaberMMMichael J. Martens

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nakamura et al. (2021) studied this question.

synapsesocial.com/papers/6a030c71daa0ebdf9f9e4503https://doi.org/10.1200/jco.20.03380
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Defining the Intensity of Conditioning Regimens: Working Definitions2009 · 1,846 citations
  2. 2Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes2017 · 22 citations
  3. 3Analyzing survival curves at a fixed point in time2007 · 317 citations
  4. 4Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation2017 · 788 citations
  5. 5Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group2011 · 554 citations